Technology-assisted treatment (TAT) can be an effective supplement to established face-to-face therapy modalities with a growing literature in substance use disorder (SUD) treatment. TAT access, interest, and familiarity are potential limitations to the use and efficacy of these approaches to treatment.
(Addict Disord Their Treatment 2016;15:149-156) I nterest in providing technologyassisted treatment (TAT) for substance use disorder (SUD) treatment has grown in recent years. [1] [2] [3] [4] Such approaches include simple information that can be accessed through the web (eg, webmd.com), electronic diaries, 5 treatment services that are provided through the web, as well as interactive treatment programs that are provided through locally sited computers or mobile phone applications. 6 TAT as a therapy add-on to face-to-face treatment has outperformed treatment as usual in randomized trials, [7] [8] [9] yielding more drug-free urine samples in a clinical trial, as well as significantly longer continuous abstinence by self-report and higher rates of drug-free urines in follow-up. Short-message service (SMS) has been shown to be effective in improving selfmanagement of medical illnesses including diabetes, hypertension, and asthma. 10, 11 Ecological momentary interventions (EMIs) are an additional form of treatment that can be delivered by handheld devices such as mobile phones, and EMIs have been developed for a variety of behaviorally related disorders including SUDs. 11 These potential TAT modalities have promising innovative features, including cost-effectiveness, 12 increased efficiency in comparison to traditional clinical models of care, and the potential to augment standardized forms of treatment provided. Exploration of these modalities has yielded a growing literature regarding patient access to technology (eg, computer, cell phone, and Internet) needed for electronically delivered services. Surveys in the general patient population have indicated that older, poorer, less educated, racial/ ethnic minorities, 13, 14 and rural dwellers are less likely to use the Internet. 15 Reported rates of Internet access among SUD treatment participants range from 20% to 72%. 14, 16, 17 A survey of computer and cell phone use by patients in SUD treatment found that those with a high school diploma or yearly income >$15 k were more likely to use computers, and African American patients were less likely to use text messaging. 14 More recent literature has demonstrated that participants in substance abuse treatment have a utilization rate of smart phone and mobile applications similar to the general US population. 18 Though more information is needed to determine the potential effectiveness of TAT for SUDs, a pragmatic issue is whether SUD treatment participants would have sufficient technology access to engage in TAT modalities. Literature suggests that participants in SUD treatment would not have technology sophisticated enough to utilize existing mobile technology. 19 Another important factor that merits consideration is SUD treatment participants' acceptance of TAT. The present report provides data from a survey of active SUD treatment participants. The goals of the survey were to characterize access to electronic devices, patient attitudes toward incorporation of technology-assisted therapies into their current treatment regimen, and to see how these characteristics varied as a function of demographic features (especially age). Characterization of these issues would expand on the existing literature regarding mobile technology ownership and possible perceived barriers to TAT utilization.
METHODS

Study Population and Setting
A cross-sectional survey of 174 individuals was conducted between November 2011 and October 2012. The survey was conducted in 5 substance treatment clinics in Baltimore City. Two programs were opioid treatment programs, 1 was an office-based opioid treatment (OBOT) site that prescribed buprenorphine as a part of a primary care practice, and 2 were outpatient SUD treatment programs that enrolled a mix of methadone/buprenorphine and nonmethadone/buprenorphine-treated patients. Participants were recruited by fliers posted at programs advertising the study. Eligibility for participation included voluntary enrollment in SUD treatment and willingness to participate in the survey. The Institutional Review Board of the Johns Hopkins Medical Institutions approved the project.
Measures
A 21-item survey was developed for this project. Items queried demographic information (sex; marital status; age; race; and ethnicity), access to electronic devices at home and other settings, attitudes toward technology-assisted substance use disorder counseling (SUDC), and opinions regarding the amount and type of counseling the patient needed.
(please see Supplemental Digital Content 1, http://links.lww.com/ADTT/A6, for a full list of the survey questions).
Data Collection
A research assistant available at selected times during program operations administered the survey in a single interaction. Survey encounters typically lasted <30 minutes. Participants were compensated $10 for completing the survey.
Data Analysis
Descriptive characteristics (mean, median, range, and SD) were used to summarize the responses. Subgroup analyses were performed; 1 analysis categorized the sample by mean age (r44 vs. Z45 y), gender, and opioid maintenance treatment (OMT) status (buprenorphine vs. methadone vs. non-OMT). Current literature suggests TAT may be an effective partial replacement for methadone maintenance treatment (MMT) counseling, 20 so analysis by OMT status was performed to provide insight into whether the different OMT groups had varying attitudes toward TAT during SUD treatment. Group comparisons were performed using t tests for continuous and w 2 analyses ADDICTIVE DISORDERS & THEIR TREATMENT Volume 15, Number 4 December 2016
for categorical measures. A regression analysis with age, availability of Internet/ e-mail access, past computer-based substance abuse counseling (SAC), and gender the independent variables, and the perceived helpfulness of computer-based SAC the dependent variable, was conducted.
RESULTS
Demographic and Participant Information
In total, 57% of participants were male, mean age was 44.8 years, and median age was 47 years (range, 19 to 64). 54% of participants were African American. 25% of participants were in MMT, 25% were receiving buprenorphine treatment, and 26% took no opioid agonist medication. 24% of participants had an unknown OMT status (Table 1 ).
Technology Access
Access to Computers and Internet
Data are presented for home and nonhome locations. In total, 56% of participants had a computer at home, and 40% had a computer only at a nonhome site ( Fig. 1 ). In addition, 88% of all participants reported that they had access to a computer at a library, treatment center, or the home of friends and family. 91% of all participants reported Internet access at home or elsewhere by computer ( Fig. 1 ). About one half (51%) of all participants had computer Internet access at home, demonstrating that most persons who had a computer at home (56% of total study population) had it connected to the Internet. Among those with Internet access at home, 51% had used their home computer for Internet access >4 times per week.
Access to Computers and the Internet as a Function of Age
Comparison between the 2 age groups (r44 vs. Z45) demonstrated that the 9% of the study population (n = 16) without Internet access were all 45 years of age or older ( Fig. 1, P<0 .0003). Further comparisons between these age groups failed to demonstrate other statistically significant differences in technology access through computer at home or at other sites.
Cellular Phone Access
Participants were surveyed for access to cell phones, as well as the capa-bility of their devices. A total of 160 of 174 (92%) of participants had cell phones, with no statistically significant difference when dividing participants into groups based on age (r44 vs. Z45 y; P = 0.53). However, there was a statistically significant difference in use of text messaging, with 92% of the younger participants (r44 y) having text-enabled phones, and only 66% of older participants (Z45 y) having such access (P<0.0002). The younger group also showed trends toward having more data and Internet access on their phone (54% vs. 40%; P = 0.09) and more app-enabled phones (37% vs. 25%; P = 0.10).
Interest in TAT for SUDC
Overall Interest
Results for questions regarding participants' interest in technologyassisted SUDC are shown in Figure 2 . Eighty-three percent of the total population was interested in technologyassisted SUDC in some capacity, with 14% not interested (3% not sure).
Participants were asked if they would expect to find technology-assisted SUD treatment helpful; response options were: very helpful, moderately helpful, little helpful, or not at all. 81% of all participants expected this method of treatment to be moderately or very helpful.
Participants were also asked what they would prefer as their treatment moving forward. The options were to start TAT exclusively, continue to have face-toface treatment, or commence a combined model with both face-to-face and TAT elements. 63% of participants responded that they would like to have TAT added to their current treatment, 33% responded they did not want to incorporate TAT at all, and 4% responded that they would want TAT alone.
Interest in TAT for SUD Counseling as a Function of Age
When the population was dichotomized by mean age, nearly identical proportions were interested in technology-assisted SUDC (Fig. 2) . However, there was a trend for the older group (Z45 y) to be less interested than the younger group (r44 y) in incorporating technology-assisted counseling into their current treatment regimen (60% vs. 74%; P = 0.062).
In total, 80% of all participants stated they would be interested in trying SUD treatment through their phone, with no difference in response when considering age (85% of those r44 y vs. 89% of those Z45 y).
Interest in TAT for SUD Counseling as a Function of Gender
Women had a higher preference rating for computer-based substance abuse counseling than men (92% vs. 76%, P<0.05), but there was no statistically significant gender difference for cell phone-based SUD treatment or face-to-face vs. TAT preference. Within the regression analysis of helpfulness of computer-base SAC, gender was the only independent variable with a significant effect (<0.005), with women more likely to find this modality helpful.
OMT Versus Non-OMT
The OMT status was known for 133 participants of the 174. Of the 133 participants with known OMT status, 33% were in MMT, 32% were in office-based buprenorphine treatment (OBOT), and 35% were in an SUD treatment program without any opioid agonist medication prescribed. There was no significant difference in general interest in TAT between groups for MMT (80% interested), OBOT (88% interested), and nonagonist group (80% interested; P = 0.75).
There was also no statistically significant difference between groups when asked about perceived helpfulness of TAT. The OBOT group tended to prefer a combined treatment model (21% face-to-face treatment only, 74% combined technology-assisted and faceto-face treatment, and 5% TAT only). These OBOT group ratings of treatment model preference (face-to-face, combined or TAT only) varied from the responses from the MMT group (41%, 55%, 5%, respectively) and the nonagonist group (41%, 59%, 0%, respectively), but were not statistically different (P = 0.13). The 3 OMT status groups had similar responses when asked if they needed more treatment, less treatment, or the same amount than they were currently receiving. Between 57 to 60% of respondents in the groups reporting they needed no more and no less treatment, and 28% to 37% reporting they needed more treatment.
Participants were asked to identify all areas in need of additional treatment. Across the 3 OMT status groups, drug use (49% of participants) and employment status (45% of participants) were most frequently identified as needing focus. There was less perceived need for more SUDC in MMT participants than noted by the other OMT groups (32% in the MMT, 60% in OBOT, and 54% in the nonagonist group) and greater need for medical illness education in participants receiving buprenorphine (30% in MMT, 44% in OBOT, and 30% in the nonagonist group).
DISCUSSION
This study adds to a growing literature and complements work on the use of TAT for delivery of SUD treatment. This survey assessed patients in outpatient SUD treatment at a variety of clinics that primarily draw from urban settings that have a high rate of opioid use disorders, and provided an opportunity to examine the interplay of age, gender, and OMT status (MMT, OBOT, or nonagonist treatment) in TAT preferences.
The present findings provide further data about access to the Internet and cell phone technologies by patients in SUD treatment. A unique feature of this report is the examination of technology access and attitudes toward TAT for SUD treatment as a function of age and gender. Although age was not significantly associated with patient attitudes, gender had a significant association. A literature search identified 1 previously published manuscript that found gender differences in attitudes toward a computer-based Spanish education modality. 21 The manuscript found that women had a higher preference the computer-based version instead of the standard paper format. No similar literature was found for computer-based treatment within the SUD field. The statistically significant gender differences in the present manuscript should be explored further in future research. These findings may correspond to treatment implications (ie, differences in the quantity of TAT utilization) between gender groups when TAT is implemented.
The age subgroup analysis was performed under the assumption that age would be a key determinant of TAT interest. Though the findings did not reach significance, there were trends that older persons (Z45 y) would be less inclined to use TAT for SUD treatment (P = 0.062). With a higherpowered sample size, a better characterization of technology access and interest along generational lines (Babyboomer, Generation X, and Generation Y/Millennial) could be obtained. With technology being introduced earlier in life to persons in younger generations, one could foresee an equilibration of rates of personal access to and TAT acceptance in SUD treatment populations across age groups.
The survey in this study characterized patients' access to electronic devices. With increasing TAT utilization, future research should explore ways to quantify patients' meaningful use of technology in their daily lives, as this could be a proxy for technology competency. Doing so would allow clinicians and researchers to anticipate client and participant difficulties when using TAT computer interfaces. Given the everchanging context of social media sites and technology devices, a universal measure of the number of social media site accounts and the number of Internet-accessible electronic devices would be a practical approach that would account for the inevitable evolution of technology content. More advanced technology interactions should also be included (eg, computer programming and website design) as such experience may be a more sensitive indicator of TAT preference. Before use of any assessment of meaningful technology use, psychometric analysis would be necessary for validation purposes.
The present report suggests that there is still a current gap in attitudes toward TAT. With an aging substance use population, 22 novel TAT modalities should consider the age of the target population, and treatment programs should use a patient-centered model to meet their clients' desired balance between TAT and face-to-face modalities. Though many participants in this study were open to TAT and would expect to find it helpful, participants voiced preference to have this therapy applied as a supplement to face-to-face interactions. Participants also noted that areas of further need were mostly related to drug use and employment, which could be specifically targeted by future technology-assisted therapeutics.
The study found that there were high rates of access to computers, the Internet, and cell phones (including phones with SMS) for these participants, although access was not always readily available in a home. These results suggest the current interest in using electronic devices as mechanisms for delivering SUD treatment would have a sizable population of participants able to access such services with some limitations (ie, men, persons with no internet access). Further research is needed to determine whether the avail-able electronic devices within the SUD treatment population contain the software capabilities and data connectivity to utilize existing SUD treatment technologies.
For cell phones, 91% of the participants surveyed had access, 40% of which used advanced cell phone technologies. These data indicate a similar prevalence as the general American adult population, of whom 91% have cell phones, 23 and 46% of whom have ''smartphones'' with Internet and e-mail capability. 24 The participant population with smartphones could potentially receive SMS or EMIs. This passive behavioral intervention has been useful in management of other chronic disease conditions 1, 10, 25 and is a potential approach for novel SUD interventions.
There are several limitations to this study. Information on OMT status was missing for 24% of participants. Initially, the investigators planned to go to clinics with homogeneous populations with this regard (eg, solely providing methadone). Over time, we expanded the target clinics and included another clinic that offered more treatment options (OMT, OBOT, and nonagonist), but the approved survey did not capture certain psychosocial factors (ie, income). Although adequate to demonstrate a difference in our primary outcome, our sample size was perhaps not sufficient to show statistically significant differences in some survey aspects, including phone access. Another limitation is the dichotomization of our attitude questions. Dichotomization has been shown to be problematic in the literature 26, 27 due to loss of variability of the responses. Future surveys should utilize Likert scale responses to capture better the variability of patient attitudes.
Despite these limitations, this work provides further evidence that electronic devices may have a valuable role in the delivery of novel treatments for persons with SUDs, and there would be a patient population with an interest in this type of treatment. Although such treatment is unlikely to supplant the traditional face-to-face counseling relationship that has been an integral part of the SUD treatment, TAT service has the potential to play an important and cost-effective role within the SUD treatment system. A clear reimbursement structure for providers utilizing TAT during SUD treatment would also make it a more viable option. 1 
CONCLUSIONS
Findings from this study help to further support the development of TAT as novel treatment aids for SUD treatment by highlighting consideration for age, gender, and meaningful use of technology. Given the rapid rate of technology evolution, an aging SUD treatment population and the financial burden of maintaining up-to-date personal technology, future research should reassess gender and age differences seen in the present study to determine whether the devices that this population possess are capable of utilizing innovative TAT. Without harmonization of new TAT interventions with the variable levels of technology access and interest in the SUD treatment population, especially across gender groups, budding innovative TAT modalities may go underutilized.
